,Date,News Headline,Article Link,Source
0,2022-01-04 07:00,Viridian Therapeutics Submits Investigational New Drug Application for VRDN-002 to the U.S. Food and Drug Administration,https://finance.yahoo.com/news/viridian-therapeutics-submits-investigational-drug-120000930.html,GlobeNewswire
1,2021-12-20 07:00,Viridian Therapeutics Announces First Subject Dosed  in Phase 1/2 Clinical Trial of VRDN-001 for Thyroid Eye Disease (TED),https://finance.yahoo.com/news/viridian-therapeutics-announces-first-subject-120000947.html,GlobeNewswire
2,2021-11-30 08:00,Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/viridian-therapeutics-announces-inducement-grants-130000426.html,GlobeNewswire
3,2021-11-15 07:00,"Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)",https://finance.yahoo.com/news/viridian-therapeutics-announces-fda-clearance-120000500.html,GlobeNewswire
4,2021-11-04 16:05,Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates,https://finance.yahoo.com/news/viridian-therapeutics-reports-third-quarter-200500208.html,GlobeNewswire
5,2021-11-03 16:05,Viridian Therapeutics to Present at Upcoming Investor Conferences,https://finance.yahoo.com/news/viridian-therapeutics-present-upcoming-investor-200500787.html,GlobeNewswire
6,2021-10-14 08:00,"Viridian Therapeutics Submits Investigational New Drug Application for VRDN-001, an IGF-1R antibody for the treatment of Thyroid Eye Disease, to the U.S. Food and Drug Administration",https://finance.yahoo.com/news/viridian-therapeutics-submits-investigational-drug-120000335.html,GlobeNewswire
7,2021-09-30 08:06,Viridian Therapeutics to Present Preclinical Data on VRDN-001 and VRDN-002 at the 90th Annual Meeting of the American Thyroid Association,https://finance.yahoo.com/news/viridian-therapeutics-present-preclinical-data-120600950.html,GlobeNewswire
8,2021-09-23 16:01,Viridian Therapeutics Announces Closing of Public Offering of Shares of Common Stock and Preferred Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares,https://finance.yahoo.com/news/viridian-therapeutics-announces-closing-public-200100536.html,GlobeNewswire
9,2021-09-21 00:22,Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock and Preferred Stock,https://finance.yahoo.com/news/viridian-therapeutics-announces-pricing-public-042200258.html,GlobeNewswire
10,2021-09-20 16:01,Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock,https://finance.yahoo.com/news/viridian-therapeutics-announces-proposed-underwritten-200100554.html,GlobeNewswire
11,2021-08-23 14:36,Strong week for Viridian Therapeutics (NASDAQ:VRDN) shareholders doesn't alleviate pain of three-year loss,https://finance.yahoo.com/news/strong-week-viridian-therapeutics-nasdaq-183601878.html,Simply Wall St.
12,2021-08-11 07:00,Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates,https://finance.yahoo.com/news/viridian-therapeutics-reports-second-quarter-110000848.html,GlobeNewswire
13,2021-08-05 08:30,Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference,https://finance.yahoo.com/news/viridian-therapeutics-participate-wedbush-pacgrow-123000622.html,GlobeNewswire
14,2021-07-26 07:30,Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer,https://finance.yahoo.com/news/viridian-therapeutics-appoints-kristian-humer-113000628.html,GlobeNewswire
15,2021-07-15 16:05,"Viridian Therapeutics Appoints Jennifer Moses, CPA to the Board of Directors and as Chair of the Audit Committee",https://finance.yahoo.com/news/viridian-therapeutics-appoints-jennifer-moses-200500999.html,GlobeNewswire
16,2021-07-14 08:00,Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/viridian-therapeutics-announces-inducement-grant-120000051.html,GlobeNewswire
17,2021-07-07 08:00,Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference,https://finance.yahoo.com/news/viridian-therapeutics-present-ladenburg-thalmann-120000038.html,GlobeNewswire
18,2021-06-10 08:00,Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference,https://finance.yahoo.com/news/viridian-therapeutics-participate-jmp-securities-120000798.html,GlobeNewswire
19,2021-05-24 10:45,"How Many Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Do Institutions Own?",https://finance.yahoo.com/news/many-viridian-therapeutics-inc-nasdaq-144546544.html,Simply Wall St.
20,2021-05-14 08:00,Viridian Therapeutics to Participate in Upcoming Investor Conferences,https://finance.yahoo.com/news/viridian-therapeutics-participate-upcoming-investor-120000511.html,GlobeNewswire
21,2021-05-06 16:05,Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates,https://finance.yahoo.com/news/viridian-therapeutics-reports-first-quarter-200500597.html,GlobeNewswire
22,2021-03-25 16:05,Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates,https://finance.yahoo.com/news/viridian-therapeutics-reports-2020-financial-200500612.html,GlobeNewswire
23,2021-03-25 14:30,"Viridian Therapeutics, Inc. to Host Earnings Call",https://finance.yahoo.com/news/viridian-therapeutics-inc-host-earnings-183000241.html,ACCESSWIRE
24,2021-03-23 04:00,Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Development and Delivery of Immune-Based Therapies,https://finance.yahoo.com/news/zenas-biopharma-launches-cross-border-080000961.html,GlobeNewswire
25,2021-03-09 16:30,Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update,https://finance.yahoo.com/news/viridian-therapeutics-host-conference-call-213000691.html,GlobeNewswire
26,2021-02-22 08:00,Viridian Therapeutics to Present at Three Upcoming Investor Conferences,https://finance.yahoo.com/news/viridian-therapeutics-present-three-upcoming-130000494.html,GlobeNewswire
27,2021-02-22 07:45,Reflecting on Viridian Therapeutics' (NASDAQ:VRDN) Share Price Returns Over The Last Three Years,https://finance.yahoo.com/news/reflecting-viridian-therapeutics-nasdaq-vrdn-124557284.html,Simply Wall St.
